Clinical Trials for Rottapharm Biotech

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Rottapharm Biotech

Clinical Trials (1)

NCT05205330
Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers
PHASE1/PHASE2Recruiting
107 participants
Started: Nov 23, 2021 · Completed: Jun 30, 2027
6 conditions2 sponsors3 locations